申请人:Allergan, Inc.
公开号:US05059611A1
公开(公告)日:1991-10-22
New 5-hydroxy-2-furanone compounds have anti-inflammatory, immunosuppressive and anti-proliferative activity and are useful in treating psoriasis and modifying calcium homeostasis.
新的5-羟基-2-呋喃酮化合物具有抗炎、免疫抑制和抗增殖活性,可用于治疗牛皮癣并调节钙稳态。